MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.bmc.2016.09.036

Медицинская библиотека · Bioorganic & medicinal chemistry · 2016

Tautomeric and non-tautomeric N-substituted 2-iminobenzimidazolines as new lead compounds for the design of anti-influenza drugs: An in vitro study.

Zarubaev Vladimir V, Morkovnik Anatolii S, Divaeva Liudmila N, Karpinskaya Liubov' A, Borodkin Gennadii S

СтатьяПеревод пока не подготовлен

Аннотация

A series of 1,3-disubstituted 2-iminobenzimidazolines as well as a number of their tautomeric analogs were synthesized. The synthesized compounds were tested for their cytotoxicity against MDCK cells and for inhibiting activity against influenza virus A/California/07/09 (H1N1)pdm09. Based on the results obtained, 50% cytotoxic concentration (CC50), 50% inhibiting concentration (IC50) and selectivity index (SI) were calculated for each compound. It was found that some of synthesized benzimidazole derivatives (7 of 22, 32%) possess strong virus-inhibiting activity against pandemic influenza virus (IC50's in low micromolar range) with quite moderate cytotoxicity (CC50 in the range of thousands micromoles). Due to their high selectivity (highest SI's=50-83) these compounds are of significant interest for further in vivo experiments as well as for further structural optimization and drug development.

Для цитирования: Zarubaev Vladimir V, Morkovnik Anatolii S, Divaeva Liudmila N, Karpinskaya Liubov' A, Borodkin Gennadii S. Tautomeric and non-tautomeric N-substituted 2-iminobenzimidazolines as new lead compounds for the design of anti-influenza drugs: An in vitro study.. Bioorganic & medicinal chemistry. 2016. DOI: 10.1016/j.bmc.2016.09.036.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.